中华实验外科杂志
中華實驗外科雜誌
중화실험외과잡지
CHINESE JOURNAL OF EXPERIMENTAL SURGERY
2011年
10期
1797-1800
,共4页
王文权%柴宗涛%朱小东%刘亮%孙惠川%汤钊猷
王文權%柴宗濤%硃小東%劉亮%孫惠川%湯釗猷
왕문권%시종도%주소동%류량%손혜천%탕쇠유
癌,肝细胞%姑息性切除术%残癌%模型,裸鼠
癌,肝細胞%姑息性切除術%殘癌%模型,裸鼠
암,간세포%고식성절제술%잔암%모형,라서
Carcinoma,hepatocellular%Palliative resection%Residual cancer%Model,nude mice
目的 建立肝癌姑息性切除术(PR)后可研究残癌生物学特性变化的转移性裸鼠人肝癌原位移植瘤模型.方法 采用单肝叶双瘤源原位接种技术建立MHCC97H原位移植瘤模型,PR切除1瘤,观察5周.测量肿瘤大小,流式细胞术计数外周血循环肿瘤细胞数,荧光显微镜和苏木素-0伊红(HE)染色检测肝内、肺、腹腔转移等,免疫组织化学染色和Western blot检测脑和肿瘤组织Vimentin表达.结果 双瘤源接种成瘤率95.6%、PR成功率95.3%、裸鼠5周总体存活率90.2%.假手术组、肝部分切除术组、PR组肿瘤大小、循环肿瘤细胞数均依次升高,肝内转移率分别为15.4%、41.7%、83.3%,肺转移率分别为61.5%、91.7%、100.0%,腹腔转移率分别为23.1%、50.0%、83.3%(P值均<0.05).手术组脑和肿瘤组织Vimentin表达均显著上调.结论 成功建立转移性裸鼠人肝癌原位移植瘤合并PR模型,可用于研究残癌生物学特性的变化.
目的 建立肝癌姑息性切除術(PR)後可研究殘癌生物學特性變化的轉移性裸鼠人肝癌原位移植瘤模型.方法 採用單肝葉雙瘤源原位接種技術建立MHCC97H原位移植瘤模型,PR切除1瘤,觀察5週.測量腫瘤大小,流式細胞術計數外週血循環腫瘤細胞數,熒光顯微鏡和囌木素-0伊紅(HE)染色檢測肝內、肺、腹腔轉移等,免疫組織化學染色和Western blot檢測腦和腫瘤組織Vimentin錶達.結果 雙瘤源接種成瘤率95.6%、PR成功率95.3%、裸鼠5週總體存活率90.2%.假手術組、肝部分切除術組、PR組腫瘤大小、循環腫瘤細胞數均依次升高,肝內轉移率分彆為15.4%、41.7%、83.3%,肺轉移率分彆為61.5%、91.7%、100.0%,腹腔轉移率分彆為23.1%、50.0%、83.3%(P值均<0.05).手術組腦和腫瘤組織Vimentin錶達均顯著上調.結論 成功建立轉移性裸鼠人肝癌原位移植瘤閤併PR模型,可用于研究殘癌生物學特性的變化.
목적 건립간암고식성절제술(PR)후가연구잔암생물학특성변화적전이성라서인간암원위이식류모형.방법 채용단간협쌍류원원위접충기술건립MHCC97H원위이식류모형,PR절제1류,관찰5주.측량종류대소,류식세포술계수외주혈순배종류세포수,형광현미경화소목소-0이홍(HE)염색검측간내、폐、복강전이등,면역조직화학염색화Western blot검측뇌화종류조직Vimentin표체.결과 쌍류원접충성류솔95.6%、PR성공솔95.3%、라서5주총체존활솔90.2%.가수술조、간부분절제술조、PR조종류대소、순배종류세포수균의차승고,간내전이솔분별위15.4%、41.7%、83.3%,폐전이솔분별위61.5%、91.7%、100.0%,복강전이솔분별위23.1%、50.0%、83.3%(P치균<0.05).수술조뇌화종류조직Vimentin표체균현저상조.결론 성공건립전이성라서인간암원위이식류합병PR모형,가용우연구잔암생물학특성적변화.
Objective To construct a metastatic human hepatocellular carcinoma (HCC) orthotopic transplantation model with palliative resection (PR) in nude mice for investigating the biological characteristics of the residual cancer,and to verify its efficacy.Methods A metastatic human HCC orthotopic nude mice model (MHCC97H) was established by using the method of bi-tumor inoculation in a single liver lobe.Two weeks after transplantation,the PR was applied to resect one tumor from the two.lobes.The tumor size was measured five weeks postresection.The flow cytometry was used to count the circulating tumor cells (CTCs) in peripheral blood.The fluorescence microscope and hematoxylin and eosin (HE)staining were adopted to determine the metastasis of the liver,lung,or abdomen.The Vimentin expression in brain or tumor tissues was detected by using immunohistochemical staining or Western blotting respectively.Results The incidence of bi-tumor formation,successful PR,and 5-week overall survival were 95.6%,95.3%,and 90.2% respectively.The tumor size and CTCs in sham operation group,liver partial hepatectomy group,and PR group were increased in gradient; the incidence of intrahepatic metastasis was 15.4%,41.7% and 83.3% ; lung metastasis rate was 61.5%,91.7% and 100.0% ; and abdomen metastasis rate was 23.1%,50.0% and 83.3%,respectively (P<0.05).The Vimentin expression in brain or tumor tissues was up-regulated after surgical resection.Conclusion A metastatic human HCC orthotopic nude mice model combined with PR is successfully constructed,and it may be used to investigate the biological characteristics of the residual cancer.